The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Gerrit-Anne Van Es

Showing 1-20 of 21 articles
Coronary interventions
A prospective multicentre randomised all-comers trial to assess the safety and effectiveness of the thin-strut sirolimus-eluting coronary stent SUPRAFLEX: rationale and design of the Thin Strut Sirolimus-eluting Stent in All Comers Population vs Everolimus-eluting Stent (TALENT) trial
Modolo R, Chichareon P, Kogame N, Asano T, Chang C, de Winter R, Kaul U, Zaman A, Spitzer E, Takahashi K, Katagiri Y, Soliman O, Van Es G-A, Morel M, Onuma Y, Serruys P
July 19, 2019 | 10.4244/EIJ-D-18-00499
Coronary interventions
Long-term ticagrelor monotherapy versus standard dual antiplatelet therapy followed by aspirin monotherapy in patients undergoing biolimus-eluting stent implantation: rationale and design of the GLOBAL LEADERS trial
Vranckx P, Valgimigli M, Windecker S, Steg P, Hamm C, Jüni P, Garcia-Garcia H, Van Es G-A, Serruys P
November 20, 2016 | 10.4244/EIJY15M11_07
Coronary interventions
Design and rationale for a randomised comparison of everolimus-eluting stents and coronary artery bypass graft surgery in selected patients with left main coronary artery disease: the EXCEL trial
Kappetein A, Serruys P, Sabik J, Leon M, Taggart D, Morice M, Gersh B, Pocock S, Cohen D, Wallentin L, Ben-Yehuda O, Van Es G-A, Simonton C, Stone G
September 18, 2016 | 10.4244/EIJV12I7A141
Coronary interventions
Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease
Escaned J, Banning A, Farooq V, Echavarría-Pinto M, Onuma Y, Ryan N, Cavalcante R, Campos C, Stanetic B, Ishibashi Y, Suwannasom P, Kappetein A, Taggart D, Morel M, Van Es G-A, Serruys P
June 10, 2016 | 10.4244/EIJV12I2A36
The coronary artery bypass graft SYNTAX Score: final five-year outcomes from the SYNTAX-LE MANS left main angiographic substudy
Farooq V, Girasis C, Magro M, Onuma Y, Morel M, Heo J, Garcia-Garcia H, Kappetein A, van den Brand M, Holmes D, Mack M, Feldman T, Colombo A, Stahle E, James S, Carrié D, Fournial G, Van Es G-A, Dawkins K, Mohr F, Morice M, Serruys P
December 27, 2013 | 10.4244/EIJV9I8A170
The CABG SYNTAX Score - an angiographic tool to grade the complexity of coronary disease following coronary artery bypass graft surgery: from the SYNTAX Left Main Angiographic (SYNTAX-LE MANS) substudy
Farooq V, Girasis C, Magro M, Onuma Y, Morel M, Heo J, Garcia-Garcia H, Kappetein A, van den Brand M, Holmes D, Mack M, Feldman T, Colombo A, Stahle E, James S, Carrié D, Fournial G, Van Es G-A, Dawkins K, Mohr F, Morice M, Serruys P
March 22, 2013 | 10.4244/EIJV8I11A196
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document
Kappetein A, Head S, Généreux P, Piazza N, Van Mieghem N, Blackstone E, Brott T, Cohen D, Cutlip D, Van Es G-A, Hahn R, Kirtane A, Krucoff M, Kodali S, Mack M, Mehran R, Rodés-Cabau J, Vranckx P, Webb J, Windecker S, Serruys P, Leon M
November 20, 2012 | 10.4244/EIJV8I7A121
The SURTAVI model: proposal for a pragmatic risk stratification for patients with severe aortic stenosis
Van Mieghem N, Head S, van der Boon R, Piazza N, de Jaegere P, Carrel T, Kappetein A, Lange R, Walther T, Windecker S, Van Es G-A, Serruys P
June 27, 2012 | 10.4244/EIJV8I2A40
The three year follow-up of the randomised “all-comers” trial of a biodegradable polymer biolimus-eluting stent versus permanent polymer sirolimus-eluting stent (LEADERS)
Wykrzykowska J, Serruys P, Buszman P, Linke A, Ischinger T, Klauss V, Eberli F, Corti R, Wijns W, Morice M, Di Mario C, van Geuns R, Van Es G-A, Jüni P, Windecker S
November 30, 2011 | 10.4244/EIJV7I7A125
Cardiovascular risk profile of patients included in stent trials; a pooled analysis of individual patient data from randomised clinical trials: insights from 33 prospective stent trials in Europe
Vranckx P, Boersma E, Garg S, Valgimigli M, Van Es G-A, Goedhart D, Serruys P
November 30, 2011 | 10.4244/EIJV7I7A134
Implantation of the biodegradable polymer biolimus-eluting stent in patients with high SYNTAX score is associated with decreased cardiac mortality compared to a permanent polymer sirolimus-eluting stent: two year follow-up results from the “all-comers” LEADERS trial
Wykrzykowska J, Garg S, Onuma Y, de Vries T, Morel M, Van Es G-A, Buszman P, Linke A, Ischinger T, Klauss V, Corti R, Eberli F, Wijns W, Morice M, Di Mario C, van Geuns R, Jüni P, Windecker S, Serruys P
September 30, 2011 | 10.4244/EIJV7I5A97
The outcome of bifurcation lesion stenting using a biolimuseluting stent with a bio-degradable polymer compared to a sirolimus-eluting stent with a durable polymer
Garg S, Wykrzykowska J, Serruys P, de Vries T, Buszman P, Trznadel S, Linke A, Lenk K, Ischinger T, Klauss V, Eberli F, Corti R, Wijns W, Morice M, Di Mario C, Tyczynski P, van Geuns R, Eerdmans P, Van Es G-A, Meier B, Jüni P, Windecker S
March 21, 2011
Intravascular ultrasound radiofrequency analysis after optimal coronary stenting with initial quantitative coronary angiography guidance: an ATHEROREMO sub-study
Sarno G, Garg S, Gomez-Lara J, Garcia-Garcia H, Ligthart J, Bruining N, Onuma Y, Witberg K, van Geuns R, de Boer S, Wykrzykowska J, Schultz C, Duckers H, Regar E, de Jaegere P, de Feyter P, Van Es G-A, Boersma E, van der Giessen WJ, Serruys P
March 21, 2011
Persistent conduction abnormalities and requirements for pacemaking six months after transcatheter aortic valve implantation
Piazza N, Nuis R, Tzikas A, Otten A, Onuma Y, Garcia-Garcia H, Schultz C, van Domburg R, Van Es G-A, van Geuns R, de Jaegere P, Serruys P
September 30, 2010
The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymer
Garg S, Sarno G, Serruys P, de Vries T, Buszman P, Linke A, Ischinger T, Klauss V, Eberli F, Corti R, Wijns W, Morice M, Di Mario C, van Geuns R, Eerdmans P, Van Es G-A, Meier B, Jüni P, Windecker S
June 30, 2010
Short- and long-term health related quality-of-life and anginal status of the Arterial Revascularisation Therapies Study part II, ARTS-II; sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease
van Domburg R, Daemen J, Morice M, De Bruyne B, Colombo A, Macaya C, Richardt G, Fajadet J, Hamm C, Van Es G-A, Wittebols K, Macours N, Stoll H, Serruys P
April 12, 2010
Tissue characterisation using intravascular radiofrequency data analysis: recommendations for acquisition, analysis, interpretation and reporting
Garcia-Garcia H, Mintz G, Lerman A, Vince G, Margolis P, Van Es G-A, Morel M, Nair A, Virmani R, Burke A, Stone G, Serruys P
June 30, 2009
Assessment of the SYNTAX score in the Syntax study
Serruys P, Onuma Y, Garg S, Sarno G, van den Brand M, Kappetein A, van Dyck N, Mack M, Holmes D, Feldman T, Morice M, Colombo A, Bass E, Leadley K, Dawkins K, Van Es G-A, Morel M, Mohr F
May 19, 2009
Early echocardiographic evaluation following percutaneous implantation with the self-expanding CoreValve ReValving System aortic valve bioprosthesis
de Jaegere P, Piazza N, Galema T, Otten A, Soliman O, Van Dalen B, Geleijnse M, Kappetein A, Garcia-Garcia H, Van Es G-A, Serruys P
November 20, 2008
Identifying stent thrombosis, a critical appraisal of the Academic Research Consortium (ARC) consensus definitions: a lighthouse and as a toe in the water
Vranckx P, Kint P-P, Morel M, Van Es G-A, Serruys P, Cutlip D
August 20, 2008

Latest news

NEW ISSUE
State of the Art on ViV-TAVI; Transseptal Punctures; Endovascular Closure and TF-TAVI; Percutaneous PVL Closure: Long-Term Outcomes; and more
October 20, 2021
STATE OF THE ART
Valve-in-valve TAVI: a practical overview
Giuseppe Tarantini et al.
October 20, 2021
AHEAD OF PRINT
Impact of LVOT calcification in transfemoral TAVI patients
L. Waldschmidt et al.
October 19, 2021
AHEAD OF PRINT
Serum caffeine causes adenosine-induced FFR overestimation
Hideaki Tanaka et al.
October 15, 2021
VIEWPOINT
My Stroke Story
Marco Noc
October 20, 2021
EDITORIAL
Transcatheter Paravalvular Leak Closure: Catch Me If You Can
Thomas Pilgrim et al.
October 20, 2021
STATE OF THE ART
Glucose-Lowering Therapy in Patients undergoing Percutaneous Coronary Intervention
Isabelle Johansson et al.
October 1, 2021
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke